Navigation Links
On-chip Mobility Shift Chip, 4-Sipper from Caliper Life Sciences

ProductsOn-chip Mobility Shift Chip, 4-Sipper from Caliper Life Sciences
Company Caliper Life Sciences
Item On-chip Mobility Shift Chip, 4-Sipper
Price 
Description Caliper offers a wide array of standard LabChip products designed to be used in combination with our AMS 90 and LabChip 3000 microfluidic platforms.
Info Caliper Life SciencesCaliper Life Sciences
Caliper Life Sciences
68 Elm St
Hopkinton, MA 01748
Customer Service: 508-435-9500
Fax Number: 508-435-3439
Web Site: http://www.caliperls.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. MDR1 Shift Assay from CHEMICON
2. Fluorogenic Chip, 4-Sipper from Caliper Life Sciences
3. Calcium Flux Antagonist Chip, 4-Sipper (coated) from Caliper Life Sciences
4. Calcium Flux Agonist Chip, 4-Sipper (coated) from Caliper Life Sciences
5. Rapidplate from Caliper Life Sciences
6. Customized Profile from Novascreen-a Caliper Life Sciences Company
7. Neurological Profile from Novascreen-a Caliper Life Sciences Company
8. Gastrointestinal Profile from Novascreen-a Caliper Life Sciences Company
9. Cardiovascular/Renal Profile from Novascreen-a Caliper Life Sciences Company
10. General Side Effect Profile I (GEN SEP I) from Novascreen-a Caliper Life Sciences Company
11. CNS Side Effect Profile (CNS SEP) from Novascreen-a Caliper Life Sciences Company
Mouse Anti-Human KRT4 Monoclonal Antibody, Unconjugated, Clone 5H5 from Abnova Corporation
Mouse Anti-Human ARHGEF11 Monoclonal Antibody, Unconjugated, Clone 2F4 from Abnova Corporation
...es ,High Quality, Functionally-Validated, Ion Chan...having a critical role in nerve and muscle functio...S and the heart. Drugs that modulate ion channels ...as neuropathic pain, cardiac arrhythmia, hypertens...
...es ,High Quality, Functionally-Validated, Ion Chan...having a critical role in nerve and muscle functio...S and the heart. Drugs that modulate ion channels ...as neuropathic pain, cardiac arrhythmia, hypertens...
Biology Products:
(Date:11/20/2009)... 19, 2009 The estimated 4.6 million Americans inv...eloping respiratory symptoms due to poor air quali...udy undertaken earlier this year by investigators ...y Medicine. , The studywhich polled more than 80...nt of individuals working in barns complained of c...
(Date:11/20/2009)... German . , In the current online issue of t...ie Eyerich and Dr. Kilian Eyerich together with th...tituto Dermopatico dell,Immacolata in Rome, presen...milestone on the way to developing new treatment m...iasis and allergic reactions and potentially also ...
(Date:11/20/2009)...y, researchers report that a class of heart medica...harmful, effect on the heart, depending on their m... the journal Circulation Research , found that be...eceptors on the heart muscle offer the most benefi...y the beta-receptors can actually undermine the st...
Breaking Biology News(10 mins):Barn personnel experience higher-than-average rates of respiratory symptoms 2Discovery of new type of immune cells regulating inflammation in chronic diseases 2Carvedilol shown to have unique characteristics among beta blockers 2Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data for AM211 a Novel Product Candidate for the Treatment of Respiratory Diseases 50392 1Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data for AM211 a Novel Product Candidate for the Treatment of Respiratory Diseases 50392 2Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products 50389 1Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products 50389 2Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products 50389 3Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products 50389 4Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products 50389 5Huge Potential Returns for Healthcare Innovators 50385 1
... drug seems very promising on paper; things are,of...omerase inhibitors,to treat cancer; they are suppo...nitely) aspect of cancer cells. Yet, something in ... them to inhibit completely,the telomerase. What t...lse? Hell no! Look out for whats stopping the drug...
... with E.coli, can lead to urinary tract infections... , “We found out that UTIs may be caused by inges...bRoy, director of Penn State’s Gastroenteric Disea...ed, she noted. , Senior author, Dr. Lee W. Riley,...oli strains isolated from patients with UTIs were ...
...tory earlier ;,progress in this area is made in th...eding the slow (and tedious) process of gene,cloni...c). ,Devices the size of a pager now have greater ...entire room. Similar advances are being,made in th...rsity of,Houston, now allowing researchers to inex...
Other Biology News:Combination therapy boosts effectiveness of telomere-directed cancer cell death 2Bacteria collection sheds light on urinary tract infections 2Inexpensive, mass-produced genes core of synthetic biology advances at UH 2
(Date:11/18/2009)...NE, Calif., Nov. 18 Ma...imetry(TM) and Measure-Through Motion and Low-Perf...rance-based Uni.H.A., one of the largest healthcar...has signed a multi-year purchasing agreement for "... The agreement offers preferred contract pricing ...
(Date:11/18/2009)... NEW YORK, Nov. 18 Reportlinker.co...vailable in its catalogue. ,, Biotechnology R...tp://www.reportlinker.com/p0164375/Biotechnology-R...rce=prnewswire&utm_medium=pr&utm_campaign=...are complex chemical compounds used in a range of ...
(Date:11/18/2009)... Promega Corporation and SwitchGear Geno...A-protein interactions. , ...mega Corporation and SwitchGear Genomics announce ...ractions. Results of a study using the HaloCHIP&tr...monstrate the ability to correlate DNA binding eve...
(Date:11/18/2009)...111 significantly reduces key cardiac enzymes at m...esented at American Heart Association 2009 Scienti...e/ - Viron Therapeutics Inc., a biotechnology comp...g protein therapeutics derived from pathogens, tod...l evaluating VT-111 (Serp-1), an anti-inflammatory...
Breaking Biology Technology:Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 2Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 3Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 4Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 2Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 3Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 4Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 5Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 6Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 7Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 8Promega and SwitchGear Publish Findings from Combined Technologies that Correlate Binding Events and Transcriptional Activity 2Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 2Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 3Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 4